Enzyme Inhibitors
Influence of ultrasound and proteolytic enzyme inhibitors on muscle degradation, tenderness, and cooking loss of hens during aging
... seen even after 7 days post mortem. The extents of nebulin degradation between treatments with exogenous enzyme inhibitors and controls were significantly different at each time point (Figure 1). ...
11
Utilization and Dose Optimization of Angiotensin Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia
... Background. Optimal use of angiotensin-converting enzyme inhibitors (ACEIs) is crucial to improve the treatment outcome in heart failure patients. However, little is known about the optimal use of ACEIs ...
9
ASSOCIATION OF ANGIOTENSIN I CONVERTING ENZYME INHIBITORS WITH THE ANGIOTENSIN II RECEPTORS ANTAGONISTS
... converting enzyme inhibitors are well known mainly in the hypertension and heart failure treatment ...ACE inhibitors and with ARB (angiotensin II receptor blocker) also called angiotensin II receptor ...
5
Development of methods for the chromatographic identification of active pharmaceutical ingredient from group of angiotensin-converting enzyme inhibitors in pharmaceuticals
... converting enzyme inhibitors is described in pharmacopeia, but the aim of our researchers was to improve to more rapid, simple, and less expensive ...
5
Synthesis and characterization of oxidovanadium complexes as enzyme inhibitors targeting dipeptidyl peptidase IV
... tridentate Schiff base ligands selectively inhibit PTP1B, and oxidova- nadium compounds carrying mixed ligands are highly potent (nano- molar activity) competitive inhibitors for PTP1B [29 – 31]. Additionally, ...
8
Underutilization of Angiotensin Converting Enzyme Inhibitors Among Heart Failure Patients
... 27. Frances C, Noguchi H, Massie BM, Browner WS, McClellan M. Are we inhibited? renal insufficiency should not preclude the use of angiotensin converting enzyme inhibitors for patients with myocardial ...
6
Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis
... angiotensin-converting enzyme levels, pulmonary function data, and angiotensin-converting enzyme inhibitor ...angiotensin-converting enzyme levels were elevated in approximately 33% of patients, ...
11
A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
... Over the past four decades, many advances have taken place in the management of heart failure, diabetic nephropathy, arterial hypertension, and chronic kidney disease. These advances have included use of ...
6
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
... guide further research, as well as the selection of ingredients and product formats that can deliver the most attractive and effective benefits to consumers. Ultimately, only randomized, double blinded, ...
19
Versatility of 7-Substituted Coumarin Molecules as Antimycobacterial Agents, Neuronal Enzyme Inhibitors and Neuroprotective Agents
... neuronal enzyme inhibitors [26], were found to exhibit promising antimycobacterial activity (see Table 1) The compounds, originally designed to incorporate coumarin structures known to show monoamine ...
23
Lichens as promising resources of enzyme inhibitors: A review
... for enzyme inhibition ...novel enzyme inhibitors which can be utilized as a remedy against various diseases and ...with enzyme inhibitory activity may be ...
12
Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors
... ACE inhibitors, ARB and beta-blockers are less effective than calcium channel blockers and diuretics in black hypertensive pa- tients with or without LVH due low plasma renin level in blacks ...
8
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae
... the inhibitors on their own were not ...ACE inhibitors are powerful blockers of the peptidyl dipeptidase activity found in a soluble fraction from both ...
10
IN SILICO ANALYSIS OF ACTIVE CONSTITUENTS OF SILYMARIN AS ΑLPHA GLUCOSIDASE ENZYME INHIBITORS IN TYPE 2 DIABETES MELLITUS
... The ADMET profile of the active constitutions of the silymarin has been estimated which showed less carcinogenicity compared with standard drugs. Even more, based on the protein-ligand interaction shows that silychristin ...
5
The design of acyl modified co enzyme A ester analogues as enzyme inhibitors
... The C-F bond has been explored as a C=O replacement due to the similarity in bond lengths, dipole moments and Van der Waals radii of the two functionalities, as well the close electronegativity of fluorine and oxygen. An ...
246
The survival benefit of angiotensin-converting enzyme inhibitors used within 16 days of myocardial infarction : a meta analysis
... ACE inhibitors after myocardial infarction cannot be made on the basis of individual analysis; however, there is a suggestion of moderate benefit which may have public health ...
141
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
... Micropuncture and morphologic studies were performed in six groups of male Munich- Wistar rats after removal of the right kidney and segmental infarction of two-thirds of the left kidney. Groups 1 and 4 received no ...
9
In vitro screening of angiotensin I-converting enzyme inhibitors from Japanese cedar (Cryptomeria japonica)
... The bioassay of three flavan-3-ols including (+)-catechin and six flavones revealed that most of these compounds have high A C E inhibitory activity. The results suggest [r] ...
6
Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization
... However, an important finding of this study was that patients presenting with a diagnosis of rest pain and taking an ACEI who underwent a LER had statistically higher amputation rates [r] ...
6
The development of PAM enzyme inhibitors and cleavable amino acids for the control of peptide hormone levels
... PAM enzyme was discussed in the Introduction with respect to its role in the production of C-terminal amidated peptide ...of inhibitors of this enzyme with the aim to their use in the treatment of ...
224